clinical trial · NCT00751166
A Comparative Double-blind, Double-dummy Study of Desloratadine (DL) 5 mg Once Daily, Cetirizine 10 mg Once Daily, and Placebo Once Daily in Patients With Chronic Idiopathic Urticaria (Study P03736)
Organon and Co·phase4·terminated·n = 149
UrticariaDesloratadineCetirizineplacebo
brief summary
This was a randomized, double-blind, parallel-group, multicenter study that used both an active control (cetirizine) and a placebo control to evaluate desloratadine 5 mg once daily during a 28-day treatment period. The active treatments and placebo were allocated in a 2:2:1 ratio.
started
Mar 1, 2004
primary completion
May 1, 2005
completion
May 1, 2005
last updated
Aug 15, 2024
official title
A Comparative Double-blind, Double-dummy Study of Desloratadine (DL) 5 mg Once Daily, Cetirizine 10 mg Once Daily, and Placebo Once Daily in Patients With Chronic Idiopathic Urticaria (CIU)
sourced from ClinicalTrials.gov · pharmadog mirrors structured fields, not the full protocol